Bristol-Myers Squibb
BMY
#178
Rank
A$178.47 B
Marketcap
A$87.31
Share price
-2.05%
Change (1 day)
23.75%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$6.55

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$6.76. In 2025 the company made an earnings per share (EPS) of A$5.18 an increase over its 2024 EPS that were of A-$6.61.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$6.5526.56%
2025A$5.18-178.28%
2024A-$6.61-213.92%
2023A$5.8130.2%
2022A$4.46-6.04%
2021A$4.75-179.29%
2020A-$5.99-281.37%
2019A$3.30-27.21%
2018A$4.53
2016A$4.00175.26%
2015A$1.45-19.83%
2014A$1.81-22.44%
2013A$2.3334.48%
2012A$1.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.00 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.86 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.06-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.76 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$46.23 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$26.01 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.96-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$3.53-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.49-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.66 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK